Company / R&D per Share
Tvardi Therapeutics, Inc. R&D per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$20.24
FY2024
5-year range
$1.54 / $20.24
FY2020-FY2024
Trend
+1216.5%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share changed +1216% YoY in FY2024, a notable deviation from the 9-year average annual change of +157%.
Based on SEC 10-K filings.
20.24 in FY2024 with a 5-year CAGR of +75.2%.
Improved from $2.02 to $20.24 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +107.0%
- 5-Year CAGR
- +75.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, r&d per share increased 1216.5% year-over-year.
- Lowest r&d per share in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -6.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $20.24 | +1216.5% |
| FY2023 | $1.54 | -23.8% |
| FY2022 | $2.02 | -11.6% |
| FY2021 | $2.28 | +41.2% |
| FY2020 | $1.62 | +31.8% |
| FY2019 | $1.23 | -18.6% |
| FY2018 | $1.51 | +94.0% |
| FY2017 | $0.78 | +40.6% |
| FY2016 | $0.55 | +45.1% |
| FY2015 | $0.38 | -64.5% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026